Protection

Groupama Insurance has adjusted its Personal Accident policy to aid brokers targeting the SME sector.

Medicines that target specific nerve cells in the brain could reverse poor mental function in people with Down's syndrome, according to new research, Bupa has said.

Chris Horlick takes a look at the latest issues in the long term care market

In November, the UK Forum for Genetics and Insurance (UKFGI) published a report which it commissioned from Professor Sandy Raeburn and myself which suggested possible options for improving the genetics moratorium.

As Progress from Royal Liver reaches its five year milestone, Mike Warr discusses a narrowing of the market's focus with Paul Robertson

Total and Permanent Disability (TPD) is causing so much hassle in the industry, that this month Anthony Burpitt goes back to basics

New HIV infections have been reduced by 17% worldwide over the past eight years.

Ellipse has come into the group risk market with the aim of changing the methods of underwriting and customer service. What do you think could be reasonably changed about the current underwriting procedure?

With the Law Commission's reform of insurance contract law almost complete - is the industry ready for change? Will the new law reflect the current industry practice and last another 100 years, asks Gill Salton?

As a general election gets closer, parties are fighting to be ‘protector of the NHS'. Jill Davies explores the possibility of NHS spending cuts and how health cash plans might change as a result